Novartis (NVS) said Thursday it has appointed Mukul Mehta as chief financial officer, effective March 16, 2026.
Mehta will succeed Harry Kirsch, who will retire after 22 years with the company.
Mukul, who has more than 20 years of experience, was recently appointed head of BPA, digital finance and tax. He will continue in this role until March next year.
Meanwhile, Kirsch will remain in the position until March 15, 2026, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.